JP2010505785A5 - - Google Patents

Download PDF

Info

Publication number
JP2010505785A5
JP2010505785A5 JP2009530810A JP2009530810A JP2010505785A5 JP 2010505785 A5 JP2010505785 A5 JP 2010505785A5 JP 2009530810 A JP2009530810 A JP 2009530810A JP 2009530810 A JP2009530810 A JP 2009530810A JP 2010505785 A5 JP2010505785 A5 JP 2010505785A5
Authority
JP
Japan
Prior art keywords
anion
pharmaceutical composition
lipid
active agent
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009530810A
Other languages
English (en)
Japanese (ja)
Other versions
JP5404402B2 (ja
JP2010505785A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2007/008659 external-priority patent/WO2008040556A1/en
Publication of JP2010505785A publication Critical patent/JP2010505785A/ja
Publication of JP2010505785A5 publication Critical patent/JP2010505785A5/ja
Application granted granted Critical
Publication of JP5404402B2 publication Critical patent/JP5404402B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009530810A 2006-10-06 2007-10-05 医薬適用のための乾燥した再構成したベシクル形成 Expired - Fee Related JP5404402B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06021093.7 2006-10-06
EP06021093 2006-10-06
PCT/EP2007/008659 WO2008040556A1 (en) 2006-10-06 2007-10-05 Dried reconstituted vesicle formation for pharmaceutical application

Publications (3)

Publication Number Publication Date
JP2010505785A JP2010505785A (ja) 2010-02-25
JP2010505785A5 true JP2010505785A5 (https=) 2013-06-20
JP5404402B2 JP5404402B2 (ja) 2014-01-29

Family

ID=38910893

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009530811A Expired - Fee Related JP5484059B2 (ja) 2006-10-06 2007-10-05 脊髄核インプラント
JP2009530810A Expired - Fee Related JP5404402B2 (ja) 2006-10-06 2007-10-05 医薬適用のための乾燥した再構成したベシクル形成

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2009530811A Expired - Fee Related JP5484059B2 (ja) 2006-10-06 2007-10-05 脊髄核インプラント

Country Status (17)

Country Link
US (3) US20090297580A1 (https=)
EP (2) EP2081551B1 (https=)
JP (2) JP5484059B2 (https=)
KR (1) KR101333279B1 (https=)
CN (3) CN102940878A (https=)
CA (1) CA2664637C (https=)
CY (1) CY1113934T1 (https=)
DK (1) DK2081551T3 (https=)
ES (2) ES2400162T3 (https=)
HR (1) HRP20130328T1 (https=)
PL (1) PL2081551T3 (https=)
PT (1) PT2081551E (https=)
RS (1) RS52706B (https=)
RU (1) RU2443412C2 (https=)
SI (1) SI2081551T1 (https=)
TW (1) TWI455731B (https=)
WO (2) WO2008040557A1 (https=)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6907884B2 (en) 2002-09-30 2005-06-21 Depay Acromed, Inc. Method of straddling an intraosseous nerve
US7258690B2 (en) 2003-03-28 2007-08-21 Relievant Medsystems, Inc. Windowed thermal ablation probe
US8361067B2 (en) 2002-09-30 2013-01-29 Relievant Medsystems, Inc. Methods of therapeutically heating a vertebral body to treat back pain
US7879103B2 (en) 2005-04-15 2011-02-01 Musculoskeletal Transplant Foundation Vertebral disc repair
US7959683B2 (en) 2006-07-25 2011-06-14 Musculoskeletal Transplant Foundation Packed demineralized cancellous tissue forms for disc nucleus augmentation, restoration, or replacement and methods of implantation
CA2957010C (en) 2008-09-26 2017-07-04 Relievant Medsystems, Inc. Systems and methods for navigating an instrument through bone
US10028753B2 (en) 2008-09-26 2018-07-24 Relievant Medsystems, Inc. Spine treatment kits
CA2790436A1 (en) 2010-02-18 2011-08-25 Osiris Therapeutics, Inc. Immunocompatible chorionic membrane products
SG10201502398RA (en) * 2010-04-27 2015-05-28 Scil Technology Gmbh Stable MIA/CD-RAP formulations
WO2013101772A1 (en) 2011-12-30 2013-07-04 Relievant Medsystems, Inc. Systems and methods for treating back pain
US20130202682A1 (en) * 2012-01-24 2013-08-08 The Trustees Of Columbia University In The City Of New York Synthetic matrix vesicles for biomimetic mineralization
SI2854769T1 (sl) * 2012-07-05 2023-09-29 Taiwan Liposome Company, Ltd. Postopki za zdravljenje artritisa
US10588691B2 (en) 2012-09-12 2020-03-17 Relievant Medsystems, Inc. Radiofrequency ablation of tissue within a vertebral body
CA2889478C (en) 2012-11-05 2020-11-24 Relievant Medsystems, Inc. Systems and methods for creating curved paths through bone and modulating nerves within the bone
US9724151B2 (en) 2013-08-08 2017-08-08 Relievant Medsystems, Inc. Modulating nerves within bone using bone fasteners
US10159646B2 (en) * 2013-08-12 2018-12-25 Altum-Avro Pharma Partnership Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery
US8986732B2 (en) 2013-08-12 2015-03-24 Helix Biopharma Corporation Biphasic lipid-vesicle compositions and methods for treating cervical dysplasia by intravaginal delivery
KR102190157B1 (ko) * 2014-12-18 2020-12-14 브라코 스위스 에스.에이. 표적화된 기체-충전 미세소포 제형
AU2016256979B2 (en) 2015-05-04 2021-01-28 Genfit Method for preparing transmembrane pH-gradient vesicles
CA2998665A1 (en) * 2015-09-18 2017-03-23 Bionet Pharma Gmbh Improvement of expression and folding in the manufacturing process of cd-rap by using a cd-rap precursor protein
US20190111178A1 (en) * 2016-04-04 2019-04-18 Gu Ventures Ab Methods and compositions for the treatment of intervertebral disc herniation
CA3061205A1 (en) * 2017-04-25 2018-11-01 Memorial Sloan Kettering Cancer Center Triterpene saponin analogues
CN111182889A (zh) 2017-08-28 2020-05-19 美商Tlc生物医药公司 缓释麻醉剂组成物及其制备方法
WO2019055901A1 (en) 2017-09-18 2019-03-21 North Carolina State University ARTIFICIAL β CELLS AND METHODS OF USE
KR102646145B1 (ko) 2018-05-31 2024-03-11 주식회사 엑소코바이오 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 모공 축소용 조성물
KR102058961B1 (ko) 2018-07-28 2019-12-24 주식회사 엑소코바이오 엑소좀의 동결건조 방법
KR102163806B1 (ko) * 2018-07-30 2020-10-07 주식회사 엑소코바이오 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 피지분비 감소용 조성물
HRP20240586T1 (hr) * 2018-10-09 2024-07-19 The University Of British Columbia Sastavi i sustavi koji sadrže transfekcijske sposobne vezikle bez organskih otapala i deterdženta i s njim povezanim postupcima
EP4027912B1 (en) 2019-09-12 2024-12-18 Relievant Medsystems, Inc. Systems for tissue modulation
WO2022011115A1 (en) 2020-07-10 2022-01-13 Relievant Medsystems, Inc. Vertebral denervation in conjunction with vertebral fusion
US12082876B1 (en) 2020-09-28 2024-09-10 Relievant Medsystems, Inc. Introducer drill
AU2021409967A1 (en) 2020-12-22 2023-08-03 Relievant Medsystems, Inc. Prediction of candidates for spinal neuromodulation
US12433668B1 (en) 2021-11-08 2025-10-07 Relievant Medsystems, Inc. Impedance stoppage mitigation during radiofrequency tissue ablation procedures
CN113995852B (zh) * 2021-11-08 2024-01-30 河北大学 Arg-脂质体微囊、微囊包封的鱼精蛋白-siRNA复合体及其制备方法和应用
CN221431621U (zh) * 2023-07-10 2024-07-30 常州富谦生物科技有限公司 一种多层膜结构

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH621479A5 (https=) * 1977-08-05 1981-02-13 Battelle Memorial Institute
FR2416008A1 (fr) * 1978-02-02 1979-08-31 Oreal Lyophilisats de liposomes
IL79114A (en) 1985-08-07 1990-09-17 Allergan Pharma Method and composition for making liposomes
FR2591105B1 (fr) * 1985-12-11 1989-03-24 Moet Hennessy Rech Composition pharmaceutique, notamment dermatologique, ou cosmetique, a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un retinoide ou un analogue structural dudit retinoide tel qu'un carotenoide.
US4897353A (en) * 1986-03-13 1990-01-30 University Of Southwestern Louisiana Cryogenic protection of phosphofructokinase using amino acids and zinc ions
US5709879A (en) * 1990-06-29 1998-01-20 Chiron Corporation Vaccine compositions containing liposomes
WO1992002208A1 (en) 1990-08-08 1992-02-20 Liposome Technology, Inc. Stable doxorubicin/liposome composition
CA2120197A1 (en) * 1993-04-02 1994-10-03 Kenji Endo Stable aqueous dispersions containing liposomes
GB9320668D0 (en) 1993-10-07 1993-11-24 Secr Defence Liposomes containing particulare materials
US6066331A (en) * 1994-07-08 2000-05-23 Barenholz; Yechezkel Method for preparation of vesicles loaded with biological structures, biopolymers and/or oligomers
IL115199A (en) * 1995-09-07 2005-05-17 Opperbas Holding Bv Composition comprising a polynucleic acid molecule in a liposome and method using said composition
US6287590B1 (en) * 1997-10-02 2001-09-11 Esperion Therapeutics, Inc. Peptide/lipid complex formation by co-lyophilization
AU5702099A (en) * 1998-09-01 2000-03-21 Millennium Pharmaceuticals, Inc. A novel protein related to melanoma-inhibiting protein and uses thereof
EP1025871A1 (en) * 1999-01-28 2000-08-09 F. Hoffmann-La Roche Ag Use of a melanoma inhibiting activity factor (MIA) for cartilage and bone repair
US7435260B2 (en) * 1999-08-13 2008-10-14 Ferree Bret A Use of morphogenetic proteins to treat human disc disease
ES2278648T3 (es) * 1999-12-06 2007-08-16 Warsaw Orthopedic, Inc. Dispositivo para tratar un disco intervertebral.
AU2002331481B2 (en) * 2001-10-03 2008-04-24 Celator Pharmaceuticals, Inc. Liposome loading with metal ions
JP2006518701A (ja) * 2002-05-24 2006-08-17 ネオファーム、インコーポレイティッド カルジオリピン組成物、その製造方法及び使用
US7169405B2 (en) * 2003-08-06 2007-01-30 Warsaw Orthopedic, Inc. Methods and devices for the treatment of intervertebral discs
BRPI0509365B8 (pt) * 2004-03-30 2021-05-25 Ilypsa Inc composição farmacêutica, kit farmacêutico, e, uso da referida composição
EP1778309B1 (en) * 2004-05-21 2010-11-17 Synthes GmbH Replacement of nucleus pulposus using a hydrogel
CA2567405A1 (en) * 2004-05-25 2005-12-08 Stryker Corporation Use of morphogenic proteins for treating cartilage defects
EP1604693A1 (en) * 2004-06-09 2005-12-14 Scil Technology GmbH In situ forming scaffold, its manufacturing and use
WO2006050327A2 (en) * 2004-10-28 2006-05-11 Alza Corporation Lyophilized liposome formulations and method
US20110071056A1 (en) * 2009-09-24 2011-03-24 Rajesh K Saini Degradable Surfactants, Including Degradable Gemini Surfactants, and Associated Methods

Similar Documents

Publication Publication Date Title
JP2010505785A5 (https=)
TWI455731B (zh) 醫藥應用的乾燥重建之囊胞結構
DK2729127T3 (en) METHODS FOR LIPOSOMES PREPARATION
JPH0545568B2 (https=)
US4196191A (en) Biological preparations
JPH0551338B2 (https=)
CA3191874A1 (en) Method of lyophilizing lipid nanoparticles
US4148876A (en) Biological preparations
JP2018502870A (ja) トラネキサム酸の多小胞リポソーム処方物
JPH09501169A (ja) 小胞に生体高分子物質を高度に充填する方法
JP6276847B2 (ja) リポソーム組成物及びその製造方法
JP4634997B2 (ja) ウィロソーム様粒子
CN105457603B (zh) 一种吸附重金属离子的纳米纤维及其制备方法
KR20160085269A (ko) 다중-미립자 약물전달 시스템
JP5487666B2 (ja) 内水相を固定化することを特徴とするリポソームの製造方法
CN119971022A (zh) 一种qs-21复合佐剂及其制备方法和应用
KR102722951B1 (ko) 단층 리포좀에서 친수성 화합물의 고효율 캡슐화
CN110035770A (zh) 新方法
CN104000782A (zh) 泰拉菌素脂质体及其制备方法
JPH10508578A (ja) 凍結乾燥リポソーム生成物の製造方法
Charnvanich et al. Effect of cholesterol on the properties of spray-dried lysozyme-loaded liposomal powders
Yadav et al. Nanotechnology integration in proniosomal drug delivery system
Valenzuela Liposome techniques for synthesis of biomimetic lipid membranes
CN120957734A (zh) 用于通过动物来源的羽毛生产角蛋白粉末的方法、用于局部施用的含有角蛋白颗粒的胶体溶液和角蛋白粉末、以及胶体溶液和角蛋白粉末的用途
JP2006273812A (ja) リポソーム製剤の製造方法